| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/2011 | EP2315766A1 Octahydroquinolizines for antidiabetic treatment |
| 05/04/2011 | EP2315765A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 05/04/2011 | EP2315764A2 Crystalline form of sunitinib and processes for its preparation |
| 05/04/2011 | EP2315763A1 Benzimidazoles and related analogs as sirtuin modulators |
| 05/04/2011 | EP2315762A2 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 05/04/2011 | EP2315761A1 Pharmaceutical compounds |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315754A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 05/04/2011 | EP2315751A1 Alkynyl alcohols as kinase inhibitors |
| 05/04/2011 | EP2315749A2 New therapeutic agents |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP2315745A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 05/04/2011 | EP2315744A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 05/04/2011 | EP2315742A2 Gabapentin enacarbil salts and processes for their preparation |
| 05/04/2011 | EP2315740A1 Fatty acid acetylated salicylates and their uses |
| 05/04/2011 | EP2315604A2 Dicarba-analgues of octreotide |
| 05/04/2011 | EP2315601A1 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 05/04/2011 | EP2315596A1 Process for extraction of glucosinolate s from broccoli seeds |
| 05/04/2011 | EP2315594A1 Methods of treating a meiotic kinesin-associated disease |
| 05/04/2011 | EP2315593A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 05/04/2011 | EP2315592A1 Treatment of pulmonary arterial hypertension |
| 05/04/2011 | EP2315591A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/04/2011 | EP2315590A1 Pyrrole inhibitors of s-nitrosoglutathione reductase |
| 05/04/2011 | EP2315589A1 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST |
| 05/04/2011 | EP2315588A1 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands |
| 05/04/2011 | EP2315587A2 Therapeutic compositions containing macitentan |
| 05/04/2011 | EP2315586A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 05/04/2011 | EP2315585A1 Controlled release treatment of depression |
| 05/04/2011 | EP2315583A2 Formulation for improving the bioavailability of a hydrophobic molecule |
| 05/04/2011 | EP2315581A1 Topical composition for the treatment of actinic keratosis |
| 05/04/2011 | EP2315521A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h 4 receptor |
| 05/04/2011 | EP2213669A9 Crystalline imidazol-5-carboxylic acid derivate |
| 05/04/2011 | EP2155669B1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 05/04/2011 | EP2139453B1 Polyaphron topical composition with vitamin d |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP2123288B1 C70 fullerene-containing liposome, method for producing the same, and use of the same |
| 05/04/2011 | EP2118051B1 New compounds, methods for their preparation and use thereof |
| 05/04/2011 | EP2091526B1 Treatment of pervasive developmental disorders |
| 05/04/2011 | EP2048145B9 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 05/04/2011 | EP2044036B1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 05/04/2011 | EP2044020B1 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 05/04/2011 | EP2035373B1 Phenyl pyrrole aminoguanidine derivatives |
| 05/04/2011 | EP2019147B1 Novel k04-0144 substances and process for production thereof |
| 05/04/2011 | EP2011497B1 Phenotropil for the prophylaxis and treatment of hemorrhagic stroke and acute phase of ischemic stroke |
| 05/04/2011 | EP1981876B1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 05/04/2011 | EP1963335B1 Process for the preparation of olanzapine |
| 05/04/2011 | EP1951716B1 Aminopyrimidines useful as kinase inhibitors |
| 05/04/2011 | EP1948237B1 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 05/04/2011 | EP1940231B1 Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition |
| 05/04/2011 | EP1879572B1 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 05/04/2011 | EP1867656B1 Compound having cyclic structure and use thereof |
| 05/04/2011 | EP1858491B1 Sublingual coated tablet |
| 05/04/2011 | EP1855661B1 Formulation for aviptadil |
| 05/04/2011 | EP1807095B1 2-o, 3-o desulfated heparin for the treatment of heparin-induced thrombocytopenia (hit) syndrome |
| 05/04/2011 | EP1802372B1 Cgrp receptor antagonists |
| 05/04/2011 | EP1797098B1 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors |
| 05/04/2011 | EP1796663B1 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 05/04/2011 | EP1794122B1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 05/04/2011 | EP1761509B1 Substituted cycloalkyl derivatives for the treatment of respiratory diseases |
| 05/04/2011 | EP1725660B1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 05/04/2011 | EP1716117B1 Ionic uv-a sunscreens and compositions containing them |
| 05/04/2011 | EP1706099B1 A medical product comprising tiotropium in a moisture-proof container |
| 05/04/2011 | EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/04/2011 | EP1633724B1 Phthalazinone derivatives |
| 05/04/2011 | EP1607395B1 Process for the preparation of amorphous rabeprazole sodium salt |
| 05/04/2011 | EP1606256B1 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 05/04/2011 | EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 05/04/2011 | EP1494650B1 Pharmaceutical formulation comprising melatonin |
| 05/04/2011 | EP1465666B1 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1429742B1 Modified release dosage forms |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1373261B1 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 05/04/2011 | EP1353684B1 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia |
| 05/04/2011 | EP1348712B1 Processes and intermediates in the synthesis of L-thymidine |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | EP1252156B1 Blockade of voltage dependent sodium channels |
| 05/04/2011 | EP0804166B1 Controlled release formulation (albuterol) |
| 05/04/2011 | CN201814877U Compound lidocaine patch |
| 05/04/2011 | CN1985901B Chinese medicine composition for promoting blood circulation and dredging collaterals and its preparing method and use |
| 05/04/2011 | CN1980672B Carboline derivatives useful in the inhibition of angiogenesis |
| 05/04/2011 | CN1968949B Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/04/2011 | CN1956954B Novel androgens |
| 05/04/2011 | CN1944420B Iguratimod crystal form and its composition |
| 05/04/2011 | CN1943756B A Chinese traditional medicinal composition used for treatment of hypertension and its preparation method |
| 05/04/2011 | CN1943681B A Chinese traditional medicinal composition for treatment of child hypophrenia and its preparation method |
| 05/04/2011 | CN1918138B Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 05/04/2011 | CN1918131B Novel inhibitors of glutaminyl cyclase |
| 05/04/2011 | CN1889829B Antimicrobial compositions comprising polymeric stabilizers |
| 05/04/2011 | CN1870997B Treatment agent for keratoconjunctival disorder |
| 05/04/2011 | CN1864822B Separating film for removing carbon monoxide, separating film assembly, method and device, an oxygen carrier with carbon monoxide removed and its pharmaceutical composition |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN1748704B Aqueous preparation for injection and its stabilizing method |
| 05/04/2011 | CN1634885B Novel mitiglinide crystalline form and its preparing process |
| 05/04/2011 | CN1500147B Improved gene expression |
| 05/04/2011 | CN102046646A C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter |
| 05/04/2011 | CN102046645A Crystal of spiroketal derivative, and process for production thereof |
| 05/04/2011 | CN102046639A New classes of GABAA/BzR ligands |
| 05/04/2011 | CN102046637A Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate |
| 05/04/2011 | CN102046633A Substituted spirocyclic cyclohexane derivatives |